ProCE Banner Activity

Integrating Recently Approved Biomarker-directed Therapy Into Clinical Practice

Slideset Download
Download this slideset to gain expert insight into best practice strategies for incorporating approved biomarker-driven therapies into clinical practice for NSCLC.

Released: October 15, 2020

Expiration: October 14, 2021

No longer available for credit.

Share

Faculty

Edward S. Kim

Edward S. Kim, MD

Chief, Section of Head and Neck Medical Oncology
Associate Professor, Thoracic/Head and Neck Medical Oncology
University of Texas M. D. Anderson Cancer Center
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Daiichi Sankyo, Inc.

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Edward S. Kim, MD

Chief, Section of Head and Neck Medical Oncology
Associate Professor, Thoracic/Head and Neck Medical Oncology
University of Texas M. D. Anderson Cancer Center
Houston, Texas